The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-8 of 8 articles
Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT
Zocca P,
van der Heijden LC,
Kok M,
Löwik M,
Hartmann M,
Stoel M,
Louwerenburg H,
de Man F,
Linssen GCM,
Knottnerus I,
Doggen CJM,
van Houwelingen K,
von Birgelen C
November 20, 2017 | 10.4244/EIJ-D-17-00634
Value of the SYNTAX score for periprocedural myocardial infarction according to WHO and the third universal definition of myocardial infarction: insights from the TWENTE trial
Tandjung K,
Lam MK,
Sen H,
de Man F,
Louwerenburg H,
Stoel M,
van Houwelingen K,
Linssen GCM,
van der Palen J,
Doggen CJM,
von Birgelen C
July 20, 2016 | 10.4244/EIJY15M08_01
Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trial
Lam MK,
Tandjung K,
Sen H,
Basalus M,
van Houwelingen K,
Stoel M,
Louwerenburg H,
Linssen GCM,
Said S,
Nienhuis M,
de Man F,
van der Palen J,
von Birgelen C
June 19, 2015 | 10.4244/EIJV11I2A32
Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial
Sen H,
Lam MK,
Tandjung K,
Basalus M,
de Man F,
Louwerenburg H,
Stoel M,
van Houwelingen K,
Löwik M,
Linssen GCM,
Said S,
Nienhuis M,
Verhorst P,
van der Palen J,
von Birgelen C
October 20, 2014 | 10.4244/EIJV10I6A117
Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and XIENCE V drug-eluting stents
Sen H,
Tandjung K,
Basalus M,
L M,
van Houwelingen K,
Stoel M,
Louwerenburg H,
de Man F,
Linssen GCM,
Nijhuis R,
Nienhuis M,
Verhorst P,
van der Palen J,
von Birgelen C
October 26, 2012 | 10.4244/EIJV8I6A104
Usefulness and safety of the GuideLiner catheter to enhance intubation and support of guide catheters: insights from the Twente GuideLiner registry
de Man F,
Tandjung K,
Hartmann M,
van Houwelingen K,
Stoel M,
Louwerenburg H,
Basalus M,
Sen H,
Löwik M,
von Birgelen C
July 27, 2012 | 10.4244/EIJV8I3A52
Latest news
AHEAD OF PRINT
Extracardiac basal annuloplasty for the treatment of secondary mitral regurgitation
FREE ARTICLE - Jérémy Bernard et al
August 11, 2022
AHEAD OF PRINT
LVOT calcification in TAVI : a post hoc analysis from the SOLVE-TAVI trial
FREE ARTICLE - Serdar Farhan et al
August 9, 2022
NEW ISSUE
The 16th EBC Expert consensus; ticagrelor or aspirin monotherapy 1 year after PCI; vasospasm and atherosclerosis in ANOCA; lifetime valve journey; and more…
August 5, 2022
AHEAD OF PRINT
RADIANCE-HTN SOLO 36-month analysis
FREE ARTICLE - Florian Rader et al
August 1, 2022
AHEAD OF PRINT
Percutaneous left atrial appendage closure with superior vascular access
FREE ARTICLE - Roberto Galea et al
August 4, 2022
AHEAD OF PRINT
Dual ProGlide vs ProGlide and FemoSeal after TAVI
FREE ARTICLE - Jonas M.D. Gmeiner et al
July 29, 2022
AHEAD OF PRINT
Stent thrombosis in comatose OHCA (ST-OHCA Study)
FREE ARTICLE - Martin Rauber et al
July 25, 2022